PUBLIC COMPANY
saveARTHEx Biotech SL
founded 2019 · Valencia, ESupdated 1mo ago
ARTHEx Biotech is a clinical-stage Spanish biotechnology company developing targeted RNA medicines for rare genetic neuromuscular disorders. A spin-off of the University of Valencia, its lead program ATX-01 is an anti-miR oligonucleotide in Phase I-IIa for myotonic dystrophy type 1 that inhibits miR-23b to restore MBNL protein function.
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
comments(0)
5-min edit window · permanent after that